Wall Street Analysts Predict a 73.42% Upside in Alphatec (ATEC): Here's What You Should Know
The consensus price target hints at a 73.4% upside potential for Alphatec (ATEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Alphatec Holdings, Inc. (ATEC) Q3 2024 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Mathew Blackman - Stifel Matt Miksic - Barclays Matthew O'Brien - Piper Sandler Caitlin Cronin - Cannacord David Saxon - Needham Sean Lee - H.C. Wainwright Drew Ranieri - Morgan Stanley Operator Good afternoon, everyone.
Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago.
Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024
24/7 Wall St. Insights With a market rotation underway, where should investors seeking opportunities in health care be looking?
Alphatec Holdings, Inc. (ATEC) Q2 2024 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Matt Blackman - Stifel Drew Ranieri - Morgan Stanley Aaron Wukmir - Lake Street Capital Markets David Saxon - Needham & Co. Jason Wittes - ROTH Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Second Quarter Financial Results.
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.43 per share a year ago.
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence.
